| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.399 | 10.936 | 15.479 | 11.385 | 11.169 | 10.430 | 10.226 | 10.014 |
| Total Income - EUR | - | - | 2.399 | 10.936 | 15.479 | 13.942 | 11.169 | 10.430 | 10.226 | 10.014 |
| Total Expenses - EUR | - | - | 1.410 | 5.338 | 7.603 | 6.526 | 8.026 | 7.063 | 7.015 | 6.981 |
| Gross Profit/Loss - EUR | - | - | 989 | 5.598 | 7.876 | 7.416 | 3.144 | 3.367 | 3.211 | 3.032 |
| Net Profit/Loss - EUR | - | - | 917 | 5.270 | 7.411 | 7.075 | 2.878 | 3.098 | 2.707 | 2.572 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioazis Zs&K S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 18 | 0 | 6.544 | 4.708 | 4.192 | 1.911 | 1.387 | 1.353 |
| Current Assets | - | - | 1.057 | 6.496 | 3.742 | 3.708 | 423 | 1.655 | 2.848 | 1.882 |
| Inventories | - | - | 25 | 53 | 24 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
| Cash | - | - | 1.032 | 6.444 | 3.717 | 3.708 | 423 | 1.655 | 2.848 | 1.872 |
| Shareholders Funds | - | - | 961 | 6.213 | 7.477 | 7.175 | 3.910 | 3.167 | 2.772 | 2.634 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 115 | 283 | 2.808 | 1.241 | 705 | 399 | 1.464 | 601 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Bioazis Zs&K S.r.l.